As a result, clinical trials represent highly sophisticated ventures that require cooperation among many people, tight deadlines, huge budgets, and, above all, safety of participants. Thus, clinical project management is critical for a successful execution of a trial in an efficient manner while generating credible data. In connection with ICH-GCP E6(R3), clinical project managers will have to pay special attention to the aspects of quality by design, risk-based approach, proportionality, and fit-for-purpose approach.

The ICH E6(R3) represents the newest version of Good Clinical Practice guideline of the International Conference for Harmonization. The Principles and Annex 1 came into force on 23 July 2025 replacing the previous guideline of E6(R2).

The Role of Clinical Project Management

Clinical project management entails the planning, coordination, implementation, monitoring and closure of a clinical trial. The work of a clinical project manager includes coordinating all the activities with regard to sponsors, CROs, investigators, vendors, regulatory team, data management, pharmacovigilance and other stakeholders.

The duties of the project manager could involve the development of timelines and budgets, coordination of activities, vendor management, milestone management, risk identification, facilitation of communication, and assignment of responsibilities. But according to the ICH E6(R3) principles, successful project management is not only about meeting a deadline or working within the budget, but about making sure that the trial is carried out in a safe and effective manner.



Understanding ICH-GCP E6(R3)

ICH-GCP represents an international standard for planning, conducting, recording, supervision, assessment, analysis, and reporting of clinical trials. The main goals that have remained unchanged throughout all revisions of ICH-GCP include the protection of the rights, welfare, and safety of trial subjects as well as obtaining reliable results from the clinical trials.

The key revision implemented in E6(R3) concerns the focus on quality by design. The approach implies shifting attention away from seeing quality as a process based mainly on monitoring and inspection to developing a strategy for integrating quality into the design of the clinical trial itself.



Applying Quality by Design

CTPMs need to determine the critical-to-quality attributes of the clinical trial during its planning phase. Such CTQ attributes may include participant safety, informed consent, randomization, investigational product management, primary end point data, data integrity, and other factors needed for answering the research questions.

When such CTQ attributes have been identified, the project team will then identify possible risks and put in place controls. E6(R3) recommends a proportional risk-based approach where more consideration needs to be given to risks that may significantly impact patient safety or validity of results of the trial.

This means that the project team cannot adopt the same approach for all processes of the trial. Rather, there should be proportional monitoring, control, technologies, and documentation.

Risk-Based Clinical Project Management

Risk management needs to be performed prior to and during the course of the trial. Risk management is something that clinical project managers need to put into place as a process of identifying, evaluating, mitigating, communication, and reviewing the risks.

Some of the steps that may be involved in a good risk management process are:

• Identification of those risks which may impact the subjects or data from the trial.
• An evaluation of the probability and consequences of the risks.
• Mitigation and controls.
• Ownership of the risk management.
• Monitoring the risks.
• Escalation of problems.
• Updates of the controls based on information gained.
  
  
  

E6(R3) highlights the fact that risk management is an iterative process and not a once-off process.



Strengthening Documentation and Oversight

It is important to note that Documentation forms an integral part of GCP compliance. Appropriate essential documents that show how the research was planned, conducted, supervised, and reported should be kept by the project team.

The Clinical Project Manager will have to ensure that the responsibilities are documented, study records are maintained appropriately, deviations and problems are evaluated, and any corrective and preventive actions are taken where necessary. Records of training, monitoring, vendors, safety, regulation, and other essential records should be kept during the course of the study.

The use of technology may help with compliance, especially the use of technology in the management of clinical data, trial documentation, monitoring, and communications. Technology needs to be appropriate to use.

Building a Culture of Compliance

Adherence to ICH E6(R3) should never just be seen as a tick-box exercise or a mandatory requirement for inspection. It should be part of the culture within the clinical trial team. Effective communication, proper training, proper roles and responsibilities, proactive risk management, and constant improvement all form part of this culture.

Project managers play a very important role in bridging the gap between various functions, as well as ensuring that the quality perspective remains in view during the course of the study.



Conclusion

ICH-GCP E6(R3) Compliance is very much related to clinical project management. In todays world of clinical research, it is no longer about just keeping to schedule and budget but a forward-thinking approach towards quality, risk, safety, and data integrity.

By implementing quality by design, taking into account critical-to-quality factors, proportionate risk management, documenting and managing effectively, clinical project managers will be able to help organizations run their trials efficiently and compliantly.

As the field of clinical research keeps advancing, the E6(R3) will provide guidance and an opportunity to embrace innovation while still maintaining the basics of Good Clinical Practice. The application of these principles will be vital for clinical project teams to conduct quality clinical trials.

Join our upcoming The Advanced Clinical Project Management and How to Comply with ICH-GCP E6(R3) Masterclass, where the crucial discussion will take place!

By Shara Najimudeen, Digital Marketing Executive, GLC Europe, Colombo Office, Sri Lanka.